Mesoblast Ltd (MESO)
7.495
+0.20
(+2.81%)
USD |
NASDAQ |
May 03, 16:00
7.495
0.00 (0.00%)
After-Hours: 19:24
Mesoblast Cash from Investing (TTM): -0.194M for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -0.194M |
March 31, 2023 | -0.257M |
December 31, 2022 | -0.34M |
September 30, 2022 | -0.336M |
June 30, 2022 | -0.232M |
March 31, 2022 | -0.408M |
December 31, 2021 | -1.288M |
September 30, 2021 | -1.665M |
June 30, 2021 | -1.647M |
March 31, 2021 | -3.292M |
December 31, 2020 | -3.049M |
September 30, 2020 | -3.101M |
June 30, 2020 | -3.273M |
March 31, 2020 | -2.203M |
December 31, 2019 | -1.60M |
Date | Value |
---|---|
September 30, 2019 | -1.214M |
June 30, 2019 | -1.00M |
March 31, 2019 | -0.638M |
December 31, 2018 | -0.585M |
September 30, 2018 | -0.566M |
June 30, 2018 | -1.153M |
March 31, 2018 | -0.713M |
December 31, 2017 | -0.246M |
September 30, 2017 | -0.194M |
June 30, 2017 | 0.142M |
March 31, 2017 | 0.096M |
December 31, 2016 | -0.401M |
September 30, 2016 | -0.51M |
June 30, 2016 | -1.727M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.292M
Minimum
Mar 2021
-0.194M
Maximum
Jun 2023
-1.476M
Average
-1.288M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
Immuron Ltd | 0.0881M |
Alterity Therapeutics Ltd | -0.0044M |
Kazia Therapeutics Ltd | -- |
Immutep Ltd | -0.0131M |
Opthea Ltd | -0.0192M |